Ricky Goldwasser
Stock Analyst at Morgan Stanley
(3.83)
# 628
Out of 4,884 analysts
236
Total ratings
64.78%
Success rate
22.24%
Average return
Main Sectors:
Stocks Rated by Ricky Goldwasser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Overweight | $270 → $283 | $261.89 | +8.06% | 16 | Jun 11, 2025 | |
| CNC Centene | Initiates: Overweight | $70 | $33.31 | +110.15% | 11 | Jun 9, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $563 → $374 | $308.55 | +21.21% | 17 | May 14, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $71 → $60 | $61.69 | -2.74% | 10 | Apr 24, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $220 → $184 | $157.12 | +17.11% | 22 | Feb 5, 2025 | |
| LFST LifeStance Health Group | Reiterates: Overweight | $10 | $4.79 | +108.77% | 8 | Apr 22, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $8 → $5.5 | $4.71 | +16.77% | 9 | Nov 10, 2023 | |
| OSCR Oscar Health | Maintains: Equal-Weight | $5 → $7.5 | $16.47 | -54.46% | 6 | Aug 30, 2023 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $19 → $12 | $13.57 | -11.57% | 8 | Aug 30, 2023 | |
| DGX Quest Diagnostics | Reiterates: Equal-Weight | $145 | $176.92 | -18.04% | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $239.58 | +52.35% | 7 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $403 → $420 | $719.30 | -41.61% | 27 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $120 | $8.51 | +1,310.11% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $549 → $620 | $239.68 | +158.68% | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $485 → $500 | $347.84 | +43.74% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $124 | $67.43 | +83.89% | 9 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $296 → $318 | $319.75 | -0.55% | 11 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $70 | $164.93 | -57.56% | 17 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $43 → $39 | $11.47 | +240.02% | 15 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $182 → $195 | $164.24 | +18.73% | 6 | Oct 21, 2020 |
Labcorp Holdings
Jun 11, 2025
Maintains: Overweight
Price Target: $270 → $283
Current: $261.89
Upside: +8.06%
Centene
Jun 9, 2025
Initiates: Overweight
Price Target: $70
Current: $33.31
Upside: +110.15%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $563 → $374
Current: $308.55
Upside: +21.21%
Doximity
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $71 → $60
Current: $61.69
Upside: -2.74%
Charles River Laboratories International
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $220 → $184
Current: $157.12
Upside: +17.11%
LifeStance Health Group
Apr 22, 2024
Reiterates: Overweight
Price Target: $10
Current: $4.79
Upside: +108.77%
GoodRx Holdings
Nov 10, 2023
Maintains: Equal-Weight
Price Target: $8 → $5.5
Current: $4.71
Upside: +16.77%
Oscar Health
Aug 30, 2023
Maintains: Equal-Weight
Price Target: $5 → $7.5
Current: $16.47
Upside: -54.46%
Alignment Healthcare
Aug 30, 2023
Maintains: Overweight
Price Target: $19 → $12
Current: $13.57
Upside: -11.57%
Quest Diagnostics
Aug 3, 2023
Reiterates: Equal-Weight
Price Target: $145
Current: $176.92
Upside: -18.04%
Jul 14, 2023
Reiterates: Overweight
Price Target: $365
Current: $239.58
Upside: +52.35%
Jan 6, 2023
Maintains: Overweight
Price Target: $403 → $420
Current: $719.30
Upside: -41.61%
Jan 6, 2023
Maintains: Overweight
Price Target: $140 → $120
Current: $8.51
Upside: +1,310.11%
Oct 31, 2022
Maintains: Overweight
Price Target: $549 → $620
Current: $239.68
Upside: +158.68%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $485 → $500
Current: $347.84
Upside: +43.74%
Oct 11, 2022
Maintains: Overweight
Price Target: $127 → $124
Current: $67.43
Upside: +83.89%
Aug 17, 2022
Maintains: Overweight
Price Target: $296 → $318
Current: $319.75
Upside: -0.55%
Jul 14, 2022
Maintains: Overweight
Price Target: $74 → $70
Current: $164.93
Upside: -57.56%
Jul 6, 2022
Maintains: Underweight
Price Target: $43 → $39
Current: $11.47
Upside: +240.02%
Oct 21, 2020
Maintains: Overweight
Price Target: $182 → $195
Current: $164.24
Upside: +18.73%